Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 1.1 Form of Underwriting Agreement
- 3.1 Certificate of Incorporation of Epien Medical, Inc. (Minnesota)
- 3.2 Articles of Incorporation for Epien Medical, Inc. (Nevada) to Be In Effect Prior to Offering
- 3.3 Amended and Restated Bylaws of Epien Medical, Inc. (Minnesota)
- 3.4 Second Amended and Restated Bylaws (Nevada) to Be In Effect Prior to Closing
- 3.5 Form of Articles of Conversion
- 3.6 Form of Plan of Conversion
- 4.2 Form of Representative's Warrant
- 4.3 Form of Common Stock Purchase Warrant In This Offering
- 4.4 Form of Warrant Agent Agreement Between Epien Medical, Inc. and Vstock Transfer, LLC
- 4.5 Form of Standard Investor Warrant
- 4.6 Form of Investor Warrant for 2005 Bridge Financing
- 4.7 Form of Convertible Promissory Note for 2005 Bridge Financing
- 4.8 Form of Investor Warrant for 2021 Bridge Financing
- 4.9 Form of Poppleton Warrant for 2021 Bridge Financing
- 4.10 Form of Convertible Promissory Note for 2021 Bridge Financing
- 10.1 Stock Option Plan (1998)
- 10.2 Form of Subscription Documents for 2005 Bridge Financing
- 10.3 Form of Subscription Documents for 2021 Bridge Financing
- 10.4 Old National Bank Commercial Credit
- 10.5 Lease Agreement for 4225 White Bear Parkway
- 10.6 Lease Agreement for 600 Highway 169 South
- 10.7 Employment Agreement with Reginald R. Dupre
- 10.8 Employment Agreement with Michael Basara
- 10.9 Employment Agreement with Steven Kavros
- 10.10 Employment Agreement with David Ufheil
- 10.12 Epien Medical, Inc. Equity Incentive Plan (2022)
- 10.13 Epien Medical, Inc. Key Employee/executive Severance and Change of Control Plan
- 10.14 Research Agreement with the University of Miami, Dated January 11, 2022, "Effects of Revity on Dermatophytes Using a Porcine Model"
- 10.15 Amendment No. 1 to Research Agreement with the University of Miami, Dated January 11, 2022, "Effects of Revity on Dermatophytes Using a Porcine Model"
- 10.16 Research Agreement with the University of Miami, Dated August 20, 2021, "Determination of the Debridement Effects of Revity on Deep Dermal Wounds"
- 10.17 Research Agreement with the University of Miami, Dated June 1, 2022, "Evaluation of the Effects of Hybenx Solution on Human Squamous Cell Carcinoma In Mouse Xenograft Model In Vivo"
- 14.1 Form of Code of Ethics of Epien Medical, Inc
- 23.1 Consent of RSM Us LLP
- 99.1 Form of Audit Committee Charter
- 99.2 Form of Compensation Committee Charter
- 99.3 Form of Nominating and Corporate Governance Committee Charter
- 99.4 Consent of Anne B. Moottz, Cpa
- 99.5 Consent of Mark D. P. Davis, MD
- 99.6 Consent of William A. Faubion, MD
- EX-FILING FEES Filing Fee Table
Associated filings
- 21 Mar 23 RW Registration withdrawal request
-
30 Sep 22 S-1 IPO registration
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use in this Registration Statement on Form S-1 of EPIEN Medical, Inc. of our report dated August 3, 2022, relating to the financial statements of EPIEN Medical, Inc.
We also consent to the reference to our firm under the heading “Experts”.
/s/ RSM US LLP
Minneapolis, Minnesota
September 30, 2022